RNAi

#Breast cancer #Cell therapy #Clinical trial #GLP-1 #Huntington's disease #LoQus23 Therapeutics #Metabolic diseases #Obesity #Osteoarthritis #Ozempic #Phesi #RNAi #Scarcell Therapeutics #Weight loss

DDW Highlights: 13 January 2026

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, a new report found breast cancer was the world’s most studied disease… Read More

#Podcasts

#Breast cancer #Cell therapy #Clinical trial #GLP-1 #Huntington's disease #LoQus23 Therapeutics #Metabolic diseases #Obesity #Osteoarthritis #Ozempic #Phesi #RNAi #Scarcell Therapeutics #Weight loss

This week in Drug Discovery (5 – 9 January) 

News round-up for 5 – 9 January by Bruno Quinney, Content Team at DDW.  This week in DDW, a new report finds breast cancer is the world’s most studied disease for the fifth year running. That same report predicts obesity to break into the top five, with weight loss a key theme across… Read More

#News

Weight loss concept
#Metabolic diseases #Obesity #RNAi

RNAi-based therapeutics could treat obesity, results show 

A new approach to treating obesity and metabolic diseases has shown promising early results in Phase I/IIa clinical trials.  ARO-INHBE and ARO-ALK7 are investigational RNA interference (RNAi) therapeutics, developed by biotechnology company Arrowhead Pharmaceuticals. Preliminary results in Phase I/IIa trials found meaningful reductions in visceral fat, total fat and liver fat, suggesting… Read More

#News

Researcher loads DNA samples for PCR analysis
#AI / data analytics / healthtech / informatics #Oncology #Queen's University Belfast #RNAi #TechBio

Belfast techbio raises £1.4m to tackle complex diseases

Belfast-based techbio company AMPLY Discovery has raised over £1.4 ($1.7) million in grant funding to develop new drugs using its AI-driven drug discovery platform. The company, which is a spin-out from the Queen’s University Belfast, was established in 2021 to commercialise a drug discovery platform developed… Read More

#Business & Investment #News